Physician profile
Manpreet Mann
NPI 1417157033
$998.89
in general payments reported to CMS, 2019-2025
18 companies · $93.61 in 2025
The $93.61 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $73.20 · 2021: $187 · 2022: $81.73 · 2023: $355 · 2024: $60.07 · 2025: $93.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.40 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $149.38 | 2023-2024 | Veozah |
| Aspira Women'S Health INC | $145.15 | 2021 | |
| Lupin INC. | $125.43 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $100.96 | 2023-2025 | |
| Exeltis, USA INC. | $96.35 | 2019-2025 | Slynd |
| Myriad Women'S Health, INC. | $85.69 | 2023 | Myrisk |
| Abbvie INC. | $73.96 | 2019-2023 | |
| Scynexis, INC. | $56.21 | 2022 | |
| Coopersurgical, INC. | $26.99 | 2025 | Sos |
| Avion Pharmaceuticals | $24.03 | 2019-2021 | |
| Roche Diagnostics Corporation | $18.08 | 2019 | |
| Hologic Sales and Service, LLC | $16.09 | 2025 | Acessa Provu System |
| Evofem Biosciences, INC. | $14.65 | 2023 | Phexxi |
| Organon LLC | $14.63 | 2023 | Jada System |
| Mission Pharmacal Company | $13.62 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $13.56 | 2022 | |
| Millicent US INC | $12.15 | 2019 | |
| Agile Therapeutics, INC. | $11.96 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manpreet Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.